We are live on ! Find out more
Jim Simons

Jim Simons Renaissance Technologies

AUM $73.4B Turnover 30.34%
1-Year Est. Return 32.8%
 

Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.

This Fund
S&P 500
This Quarter Est. Return
+9.15%
1 Year Est. Return
+32.8%
3 Year Est. Return
+177.41%
5 Year Est. Return
+184.82%
10 Year Est. Return
+833.44%
AUM
$100B
AUM Growth
-$15.7B
Cap. Flow
-$21.6B
Cap. Flow %
-21.62%
Top 10 Hldgs %
15.09%
Holding
3,879
New
490
Increased
1,152
Reduced
1,670
Closed
543
Avg Time Held
2.7 years
Top 10 Avg Time Held
1.2 years
Top 20 Avg Time Held
1.7 years

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$276M
2
PG icon
Procter & Gamble
PG
+$243M
3
ADI icon
Analog Devices
ADI
+$188M
4
AMD icon
Advanced Micro Devices
AMD
+$171M
5
HD icon
Home Depot
HD
+$162M

Top Sells

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$1.95B
2
BMY icon
Bristol-Myers Squibb
BMY
+$778M
3
WMT icon
Walmart
WMT
+$723M
4
ZM icon
Zoom
ZM
+$642M
5
CMG icon
Chipotle Mexican Grill
CMG
+$573M

Sector Composition

Rank Sector Weight
1 Healthcare 23.3%
2 Technology 17.17%
3 Consumer Staples 12.21%
4 Communication Services 9.94%
5 Consumer Discretionary 9.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
ZM icon
1
Zoom
ZM
$23.7B
$2.47B 2.46%
5,247,859
-2,008,176
-28% -$642M
2020 Q1
2 quarters
NVO icon
2
Novo Nordisk
NVO
$167B
$1.95B 1.95%
56,242,462
-1,177,200
-2% -$39.2M
2013 Q2
29 quarters
BMY icon
3
Bristol-Myers Squibb
BMY
$120B
$1.84B 1.84%
30,576,427
-12,920,704
-30% -$778M
2016 Q2
17 quarters
VRTX icon
4
Vertex Pharmaceuticals
VRTX
$131B
$1.42B 1.41%
5,206,932
-574,400
-10% -$158M
2017 Q1
14 quarters
CMG icon
5
Chipotle Mexican Grill
CMG
$45B
$1.42B 1.41%
56,952,100
-23,765,000
-29% -$573M
2016 Q4
15 quarters
VRSN icon
6
VeriSign
VRSN
$27.5B
$1.35B 1.34%
6,573,190
-737,500
-10% -$152M
2013 Q2
29 quarters
BIDU icon
7
Baidu
BIDU
$21.1B
$1.33B 1.33%
10,545,158
+881,301
+9% +$109M
2019 Q3
4 quarters
ABBV icon
8
AbbVie
ABBV
$506B
$1.18B 1.18%
13,470,803
-5,551,066
-29% -$523M
2018 Q1
10 quarters
BIIB icon
9
Biogen
BIIB
$36.9B
$1.08B 1.08%
3,816,961
-88,961
-2% -$24.8M
2018 Q1
10 quarters
TGT icon
10
Target
TGT
$75.1B
$1.08B 1.07%
6,829,197
-1,051,700
-13% -$144M
2019 Q1
6 quarters
TEAM icon
11
Atlassian
TEAM
$33.9B
$1.07B 1.07%
5,897,814
-937,199
-14% -$167M
2016 Q2
17 quarters
MNST icon
12
Monster Beverage
MNST
$85.5B
$1B 1%
49,937,160
-1,693,200
-3% -$33.4M
2014 Q1
26 quarters
KR icon
13
Kroger
KR
$40.4B
$988M 0.99%
29,128,088
+2,916,000
+11% +$101M
2019 Q2
5 quarters
PANW icon
14
Palo Alto Networks
PANW
$282B
$962M 0.96%
23,571,624
-6,369,888
-21% -$265M
2015 Q2
21 quarters
PDD icon
15
Pinduoduo
PDD
$119B
$866M 0.86%
11,675,773
+525,093
+5% +$45M
2019 Q2
5 quarters
FNV icon
16
Franco-Nevada
FNV
$43.1B
$747M 0.75%
5,354,183
-317,900
-6% -$47.2M
2014 Q1
26 quarters
GSK icon
17
GSK
GSK
$95.7B
$690M 0.69%
14,663,723
-1,777,280
-11% -$89M
2013 Q2
29 quarters
HZNP
18
DELISTED
Horizon Therapeutics
HZNP
$682M 0.68%
8,780,875
-1,532,000
-15% -$105M
2017 Q2
13 quarters
EBAY icon
19
eBay
EBAY
$50.7B
$670M 0.67%
12,850,934
-428,400
-3% -$23.6M
2019 Q1
6 quarters
HUM icon
20
Humana
HUM
$46.8B
$661M 0.66%
1,598,142
-729,100
-31% -$293M
2015 Q2
21 quarters
ABMD
21
DELISTED
Abiomed Inc
ABMD
$625M 0.62%
2,257,123
+7,001
+0.3% +$2.02M
2015 Q1
22 quarters
MOH icon
22
Molina Healthcare
MOH
$10.4B
$614M 0.61%
3,355,159
-321,300
-9% -$58.5M
2013 Q2
29 quarters
B icon
23
Barrick Mining
B
$51.4B
$603M 0.6%
21,467,447
-5,338,762
-20% -$152M
2014 Q2
25 quarters
REGN icon
24
Regeneron Pharmaceuticals
REGN
$95.2B
$600M 0.6%
1,072,362
+182,262
+20% +$111M
2017 Q3
12 quarters
DPZ icon
25
Domino's
DPZ
$11.5B
$589M 0.59%
1,385,425
-154,300
-10% -$61.4M
2013 Q2
29 quarters

Similar funds

Jim Simons's Q3 2020 Portfolio in Review

As of Q3 2020, Jim Simons held 3,879 positions worth $100B, down 14% from $116B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Jim Simons withdrew a net $21.6B in Q3 2020, closing 543 positions and reducing 1,670 holdings. Its most notable exit was Alibaba, an estimated $426M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, down from 24% a quarter earlier, followed by Technology and Consumer Staples.

Against the trend, Jim Simons opened a new position in Microsoft worth $277M.

  • Jim Simons's largest Q3 2020 buy was Microsoft: 1,315,812 shares worth $277M.
  • Jim Simons added most to Procter & Gamble in Q3 2020, an estimated $243M increase.
  • Jim Simons's biggest Q3 2020 reduction was Tesla, cutting an estimated $1.95B.
  • Jim Simons fully exited Alibaba in Q3 2020, selling an estimated $426M.
  • Jim Simons's ten largest holdings make up 15% of its $100B portfolio in Q3 2020.
  • Jim Simons opened 490 new positions and closed 543 in Q3 2020.
  • Jim Simons's portfolio value fell 14% quarter-over-quarter to $100B.

Based on Renaissance Technologies's 13F filing for Q3 2020, filed 13 Nov 2020.